---
title: "Mestranol - Endometriosis"
sidebar: mydoc_sidebar
permalink: db01357-mesh-d004715-1.html
toc: false 
---


Path ID: `DB01357_MESH_D004715_1`
{% include image.html url="images/db01357-mesh-d004715-1.png" file="db01357-mesh-d004715-1.png" alt="db01357-mesh-d004715-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D008656">MESH:D008656 </a> | Mestranol | Drug |
| <a href="https://identifiers.org/MESH:D004715">MESH:D004715 </a> | Endometriosis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Mestranol | TREATS | Endometriosis |
|---------|-----------|---------|

Comment: Mestranol is a biologically inactive prodrug of ethinylestradiol, which it is demethylated in the liver with a conversion efficiency of 70%. Mestranol is used as an estrogen component of many combined oral contraceptives. The combined oral contraceptives show efficacy in endometriosis symptoms management, but not estrogen component itself.

Reference: 
  - [https://go.drugbank.com/drugs/DB01357](https://go.drugbank.com/drugs/DB01357)
  - [https://pubmed.ncbi.nlm.nih.gov/31488888/](https://pubmed.ncbi.nlm.nih.gov/31488888/)
